Exane Derivatives Portfolio Holdings

Exane Derivatives

  • $157 Million
  • Q2 2022

Exane Derivatives has filed its 13F form on July 12, 2022 for Q2 2022 where it was disclosed a total value porftolio of $157 Million distributed in 758 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Spdr S&P 500 ETF Trust with a value of $8.79M, Microsoft Corp with a value of $6.17M, Merck & Co., Inc. with a value of $5.92M, Cameco Corp with a value of $5.21M, and Ishares Inc Msci Global Select with a value of $3.52M.

Examining the 13F form we can see an decrease of $167M in the current position value, from $323M to 157M. Also it can be appreciated an additional of 57 stocks purchases and 316 closed positions.

Below you can find more details about Exane Derivatives portfolio as well as his latest detailed transactions.

Portfolio value $157 Million
ETFs: $28.2 Million
Technology: $25.8 Million
Healthcare: $20.9 Million
Energy: $19.3 Million
Industrials: $11.4 Million
Consumer Defensive: $10.7 Million
Financial Services: $10.4 Million
Consumer Cyclical: $10.2 Million
Other: $19.7 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.25T
$6.17 Million 3.94% of portfolio
24,041
Q2 2022 Reduced 14.21%
$248B
$5.92 Million 3.78% of portfolio
64,879
Q2 2022 Reduced 4.44%
$270B
$3.4 Million 2.17% of portfolio
54,039
Q2 2022 Reduced 3.67%
$200B
$2.29 Million 1.46% of portfolio
16,200
Q2 2022 Reduced 25.05%
$280B
$2.15 Million 1.37% of portfolio
14,857
Q2 2022 Reduced 20.69%
$378B
$1.88 Million 1.2% of portfolio
10,612
Q2 2022 Added 87.92%
$215B
$1.85 Million 1.18% of portfolio
7,508
Q2 2022 Reduced 15.33%
$422B
$1.59 Million 1.02% of portfolio
3,325
Q2 2022 Reduced 14.85%
$204B
$1.6 Million 1.02% of portfolio
16,945
Q2 2022 Reduced 15.11%
$697B
$1.43 Million 0.91% of portfolio
12,673
Q2 2022 Reduced 11.86%
$1.32T
$1.37 Million 0.88% of portfolio
8,517
Q2 2022 Added 20.01%
$344B
$1.28 Million 0.82% of portfolio
7,751
Q2 2022 Reduced 16.0%
$280B
$1.2 Million 0.77% of portfolio
2,521
Q2 2022 Reduced 25.87%
$218B
$1.07 Million 0.68% of portfolio
9,429
Q2 2022 Reduced 10.29%
$240B
$988,000 0.63% of portfolio
23,175
Q2 2022 Added 10.72%
$220B
$680,000 0.43% of portfolio
1,431
Q2 2022 Reduced 1.11%
$336B
$586,000 0.37% of portfolio
3,870
Q2 2022 Reduced 61.39%
$398B
$532,000 0.34% of portfolio
3,705
Q2 2022 Reduced 3.77%
$208B
$506,000 0.32% of portfolio
1,384
Q2 2022 Reduced 2.6%
$231B
$401,000 0.26% of portfolio
1,447
Q2 2022 Reduced 34.64%
$441B
$379,000 0.24% of portfolio
4,434
Q2 2022 Reduced 59.69%
$504B
$320,000 0.2% of portfolio
1,015
Q2 2022 Reduced 45.87%
$1.14T
$244,000 0.16% of portfolio
2,245
Q2 2022 Reduced 12.58%
$730B
$256,000 0.16% of portfolio
790
Q2 2022 Reduced 68.16%
$310B
$232,000 0.15% of portfolio
1,517
Q2 2022 Reduced 44.59%
$405B
$73,000 0.05% of portfolio
423
Q2 2022 Reduced 51.21%
$210B
$73,000 0.05% of portfolio
255
Q2 2022 Reduced 87.8%
$1.17T
$66,000 0.04% of portfolio
609
Q2 2022 Added 18.48%
$200B
$17,000 0.01% of portfolio
10
Q2 2022 Reduced 87.95%
$209B
$0 0.0% of portfolio
1
Q1 2022 Reduced 99.91%
$402B
$0 0.0% of portfolio
3
Q2 2022 Reduced 99.27%

Summary

  • Portfolio
  • No. of Stocks 758
  • Current Value $157 Million
  • Prior Value $323 Million
  • Filing
  • Period Q2 2022
  • Filing Date July 12, 2022
  • Form Type 13F-HR
  • Activity in Q2 2022
  • New Purchases 57 stocks
  • Additional Purchases 90 stocks
  • Sold out of 316 stocks
  • Reduced holdings in 353 stocks
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email